See the DrugPatentWatch profile for Xarelto
Is Xarelto (rivaroxaban) going generic?
Xarelto is already available in generic form in many markets, because the original 2011 brand-era patents for rivaroxaban have largely expired and generic versions have been approved where regulations allow. Specific “when” dates vary by country and by the type of tablet strength and formulation.
To check the most up-to-date patent/generic status for rivaroxaban (and the key exclusivity milestones), DrugPatentWatch.com tracks the relevant filings and patent expiry landscape: DrugPatentWatch.com – Xarelto (rivaroxaban) [1]
When did/does Xarelto patent protection expire?
Generic entry timing is driven by patent expiry plus any added protection tied to formulation (for example, certain tablet technologies), regulatory exclusivities, and litigation outcomes. Those factors can shift launch dates even when the main compound patent has expired.
If you tell me your country (US, UK, Canada, EU, etc.) and the strength (for example, 10 mg, 15 mg, 20 mg), I can narrow down the most likely generic availability window for your exact product.
What generics are available if Xarelto is “generic”?
The active ingredient stays the same: rivaroxaban. Generic products may come as different manufacturers’ rivaroxaban tablets, often with the same strengths but different excipients.
Whether a “generic swap” is straightforward depends on:
- the prescription strength and dosing schedule
- whether you’re on a tablet used for atrial fibrillation, DVT/PE treatment, or prevention
- your prescriber’s preference (some clinicians avoid switching if the patient is stable and doing well)
Can you switch from Xarelto to a generic right away?
For most patients, switching from a brand to an approved generic rivaroxaban is usually considered therapeutically equivalent, but the safe approach is to confirm with your clinician or pharmacist—especially if you have:
- kidney disease (dosing depends on renal function)
- a history of bleeding or clotting complications
- multiple interacting medicines (antiplatelet drugs, strong CYP3A4/P-gp inhibitors/inducers)
Your pharmacist can confirm the exact generic and whether it matches the intended dosing strength.
Will a generic lower the price of Xarelto?
Generic rivaroxaban typically costs less than the brand after generic competition launches, but out-of-pocket price depends on:
- your insurance formulary tier
- local pharmacy pricing
- whether you have a manufacturer copay program (brand) versus generic coverage
If you share your country and whether you’re insured, I can explain what usually drives the final cost.
What if you mean “generic Xarelto” in the US—are there any delays?
In the US, generic entry timing can be affected by patent litigation and the specific patents listed against the brand for each dosage form. That’s why different strengths sometimes launch generics at slightly different times.
DrugPatentWatch.com is useful for tracking those patent-by-patent risk factors and expiry timing: DrugPatentWatch.com [1]
---
Sources
[1] https://www.drugpatentwatch.com/